Research ArticleAccepted Article
Tuberculosis in biologic-naïve patients with rheumatoid arthritis - risk factors and tuberculosis characteristics
Johanna Karlsson Sundbaum, Elizabeth V. Arkema, Judith Bruchfeld, Jerker Jonsson, Johan Askling and Eva Baecklund
The Journal of Rheumatology April 2021, jrheum.201251; DOI: https://doi.org/10.3899/jrheum.201251
Johanna Karlsson Sundbaum
Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Department of Health Sciences, Luleå University of Technology, Luleå, Sweden; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm Sweden; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Public Health Agency of Sweden, Stockholm, Sweden; Rheumatology Division, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. Funding:No specific funding was received from any bodies in the public, commercial or notfor-profit sectors to carry out the work described in this article. J. Karlsson Sundbaum PhD, Assistant Professor Luleå University of Technology, E.V. Arkema PhD, Assistant Professor Karolinska institutet, J. Bruchfeld PhD, Senior consultant Karolinska University Hospital, J. Jonsson PhD, Senior consultant Public Health Agency of Sweden, J. Askling PhD professor Karolinska institutet, E. Baecklund PhD, Associate professor Uppsala University. Corresponding author: Johanna Sundbaum, Rheumatology Unit, Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, E-mail: johanna.sundbaum@ltu.se Key words: rheumatoid arthritis, tuberculosis, biologic–naïve, risk factors
Elizabeth V. Arkema
Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Department of Health Sciences, Luleå University of Technology, Luleå, Sweden; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm Sweden; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Public Health Agency of Sweden, Stockholm, Sweden; Rheumatology Division, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. Funding:No specific funding was received from any bodies in the public, commercial or notfor-profit sectors to carry out the work described in this article. J. Karlsson Sundbaum PhD, Assistant Professor Luleå University of Technology, E.V. Arkema PhD, Assistant Professor Karolinska institutet, J. Bruchfeld PhD, Senior consultant Karolinska University Hospital, J. Jonsson PhD, Senior consultant Public Health Agency of Sweden, J. Askling PhD professor Karolinska institutet, E. Baecklund PhD, Associate professor Uppsala University. Corresponding author: Johanna Sundbaum, Rheumatology Unit, Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, E-mail: johanna.sundbaum@ltu.se Key words: rheumatoid arthritis, tuberculosis, biologic–naïve, risk factors
Judith Bruchfeld
Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Department of Health Sciences, Luleå University of Technology, Luleå, Sweden; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm Sweden; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Public Health Agency of Sweden, Stockholm, Sweden; Rheumatology Division, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. Funding:No specific funding was received from any bodies in the public, commercial or notfor-profit sectors to carry out the work described in this article. J. Karlsson Sundbaum PhD, Assistant Professor Luleå University of Technology, E.V. Arkema PhD, Assistant Professor Karolinska institutet, J. Bruchfeld PhD, Senior consultant Karolinska University Hospital, J. Jonsson PhD, Senior consultant Public Health Agency of Sweden, J. Askling PhD professor Karolinska institutet, E. Baecklund PhD, Associate professor Uppsala University. Corresponding author: Johanna Sundbaum, Rheumatology Unit, Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, E-mail: johanna.sundbaum@ltu.se Key words: rheumatoid arthritis, tuberculosis, biologic–naïve, risk factors
Jerker Jonsson
Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Department of Health Sciences, Luleå University of Technology, Luleå, Sweden; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm Sweden; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Public Health Agency of Sweden, Stockholm, Sweden; Rheumatology Division, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. Funding:No specific funding was received from any bodies in the public, commercial or notfor-profit sectors to carry out the work described in this article. J. Karlsson Sundbaum PhD, Assistant Professor Luleå University of Technology, E.V. Arkema PhD, Assistant Professor Karolinska institutet, J. Bruchfeld PhD, Senior consultant Karolinska University Hospital, J. Jonsson PhD, Senior consultant Public Health Agency of Sweden, J. Askling PhD professor Karolinska institutet, E. Baecklund PhD, Associate professor Uppsala University. Corresponding author: Johanna Sundbaum, Rheumatology Unit, Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, E-mail: johanna.sundbaum@ltu.se Key words: rheumatoid arthritis, tuberculosis, biologic–naïve, risk factors
Johan Askling
Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Department of Health Sciences, Luleå University of Technology, Luleå, Sweden; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm Sweden; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Public Health Agency of Sweden, Stockholm, Sweden; Rheumatology Division, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. Funding:No specific funding was received from any bodies in the public, commercial or notfor-profit sectors to carry out the work described in this article. J. Karlsson Sundbaum PhD, Assistant Professor Luleå University of Technology, E.V. Arkema PhD, Assistant Professor Karolinska institutet, J. Bruchfeld PhD, Senior consultant Karolinska University Hospital, J. Jonsson PhD, Senior consultant Public Health Agency of Sweden, J. Askling PhD professor Karolinska institutet, E. Baecklund PhD, Associate professor Uppsala University. Corresponding author: Johanna Sundbaum, Rheumatology Unit, Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, E-mail: johanna.sundbaum@ltu.se Key words: rheumatoid arthritis, tuberculosis, biologic–naïve, risk factors
Eva Baecklund
Rheumatology Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Department of Health Sciences, Luleå University of Technology, Luleå, Sweden; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm Sweden; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Public Health Agency of Sweden, Stockholm, Sweden; Rheumatology Division, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. Funding:No specific funding was received from any bodies in the public, commercial or notfor-profit sectors to carry out the work described in this article. J. Karlsson Sundbaum PhD, Assistant Professor Luleå University of Technology, E.V. Arkema PhD, Assistant Professor Karolinska institutet, J. Bruchfeld PhD, Senior consultant Karolinska University Hospital, J. Jonsson PhD, Senior consultant Public Health Agency of Sweden, J. Askling PhD professor Karolinska institutet, E. Baecklund PhD, Associate professor Uppsala University. Corresponding author: Johanna Sundbaum, Rheumatology Unit, Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, E-mail: johanna.sundbaum@ltu.se Key words: rheumatoid arthritis, tuberculosis, biologic–naïve, risk factors
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Tuberculosis in biologic-naïve patients with rheumatoid arthritis - risk factors and tuberculosis characteristics
Johanna Karlsson Sundbaum, Elizabeth V. Arkema, Judith Bruchfeld, Jerker Jonsson, Johan Askling, Eva Baecklund
The Journal of Rheumatology Apr 2021, jrheum.201251; DOI: 10.3899/jrheum.201251
Accepted manuscript
Tuberculosis in biologic-naïve patients with rheumatoid arthritis - risk factors and tuberculosis characteristics
Johanna Karlsson Sundbaum, Elizabeth V. Arkema, Judith Bruchfeld, Jerker Jonsson, Johan Askling, Eva Baecklund
The Journal of Rheumatology Apr 2021, jrheum.201251; DOI: 10.3899/jrheum.201251